At present, the distribution structure in the European and American markets is heavily inclined towards national warehouses both regionally and centrally. Developing warehouse structures and outsourcing to logistics service providers is the a key focus in some pharmaceutical manufacturers. Low cost and greater visibility in the supply chain are the main advantages of outsourcing logistics services and is becoming an integral part of strategy.
The primary driving factor for the growth of this market include strict regulations in the form of Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP), which summarize the criteria relating to the purchase, storage and export of medicines. In addition, factors like increasing demand for temperature sensitive pharmaceutical products and delivery methods could contribute to the growth of this market.
Resricting factors include issues related to confidentiality of the proprietary information, loss of control and deteriorating services.
Geographically, Asia-Pacific dominates the market, which is evident from the presence of key players, and lower logistics costs.
Panalpina, DHL, FedEx and UPS are amongst the leading logistic service providers in the industry. The global market for bio-pharmaceutical logistics was valued at USD 61.1 billion in 2014 and is expected to reach USD 91.0 billion by 2020f, growing at a CAGR of 6.9% during the forecast period of 2015e to 2020f.
Download the full report: https://www.reportbuyer.com/product/3870304/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bio-pharmaceutical-logistics-global-market-report-2016-300320238.html